Participation in Cancer Clinical Trials: Researching the Causes of Low Accrual
Author:
- Rn Pamela Hallquist VialeRVRn Pamela Hallquist Viale
- 1 March 2016
- journal article
- Published by Harborside Press, LLC in Journal of the Advanced Practitioner in Oncology
- Vol. 7 (2) , 143-144
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Predicting Low Accrual in the National Cancer Institute’s Cooperative Group Clinical TrialsJNCI: Journal of the National Cancer Institute, 2015
- Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology GroupsClinical Cancer Research, 2012
- Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trialsClinical Trials, 2011